clinically evident News
-
IONIQ Presents Lung Cancer Trial Results at ATS 2022
IONIQ Sciences is proud of our team members who presented our latest lung cancer clinical trial results in a poster today at the American Thoracic Society meeting in San Francisco, CA. This was a great honor to highlight our growing bioimpedance clinical evidence that continues to demonstrate the possibility of a non-invasive, low-cost, early-stage lung cancer diagnosis. Furthermore, the ...
-
iRhythm launches Clinical Resource Center for clinicians’ convenience
iRhythm Technologies, Inc. is excited to announce the addition of a Clinical Resource Center (CRC) to its website. The CRC was designed to make it easy for clinicians to access clinical evidence, on-demand webinars, and case studies through one centralized location. Clinicians will use the CRC as a gateway to published clinical articles. Summaries of significant ...
-
IONIQ Receives Three Awards including ‘Best Medical Technology Company 2022’
IONIQ Sciences is humbled to be recognized with three separate awards from ‘Global 100‘ especially during ‘Lung Cancer Hope Month.’ These three awards and earlier designation by the US FDA as a ‘Breakthrough Device‘ is further validation of our growing clinical evidence library from seven trials at 24 sites with 1.2K subjects and more than 20M data points. ...
-
Symple Surgical Announces Collaboration and Development Partnership with Global Medical Device Manufacturer
Flagstaff, Arizona – August 28, 2016 – Symple Surgical Inc. (“SSI”) announced today the signing of a development agreement with a confidential strategic partner whose long standing market leadership position in endovascular device therapies makes it an ideal partner to continue development of novel microwave ablation technologies. As part of this agreement both parties ...
-
Novel radiometry guided microwave ablation technology set to advance with National Institutes of Health Small Business Innovation Research Award
Flagstaff, Arizona – October 9, 2018 – Symple Surgical Inc. (SSI) announced today that we have received a National Institutes of Health (NIH) Small Business Innovation Research (SBIR) Phase I Grant Award totaling $225,000.00. This award will leverage the ongoing R&D and commercialization initiatives with Duke University to pursue the integration of radiometric thermal feedback ...
-
Alleviant Medical Receives Breakthrough Device Designation From FDA for Transcatheter Technology
Alleviant Medical Inc., a privately-held medical device company, today announced that the US Food and Drug Administration (FDA) has granted the company a Breakthrough Device designation for its transcatheter technology. The technology offers a no-implant interatrial shunt therapy for patients suffering from heart failure with preserved (HFpEF) and mid-range ejection fraction (HFmrEF) who remain ...
-
Endologix Announces First Commercial Implant of ALTO Abdominal Stent Graft System Outside of United States
Furthering its mission to transform the treatment of aortic disorders, Endologix, Inc. (OTC: ELGXQ) (“Endologix” or the “Company”) today announced the first implant of its recently approved ALTO® endograft outside of the United States, completed by Andrew Holden, MD, and Andrew Hill, MD, of Auckland City Hospital, Auckland, New Zealand. “With the 7 mm infrarenal ...
-
Tactile Medical to Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, today announced that management will participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference. Management will participate in a ...
-
Transpara breast AI; strong clinical evidence evolves into real life screening use
The Transpara AI breast care solution, now being used in over 30 countries worldwide to find breast cancers faster and earlier, has 'remarkable potential' to reduce Radiologists' workload, according to a leading research team in Spain. The team at the renowned University Hospital Reina Sofia in Cordoba, has launched a world first prospective 2D AND 3D study to see how they could help ...
-
Beyond Death Valley: Medtech Veteran Breathes New Life into HIFU Company
Ryan Rhodes, new CEO of EDAP USA was featured in MDDI this week. Rhodes hales from Intuitive Surgical where he helped build the DaVinci Robot brand. He compares HIFU to the early days of robotic surgery: “The HIFU market is still in its infancy, and Rhodes said it reminds him of his early days at Intuitive Surgical, when the Irvine, CA-based robotics company was focused on prostate cancer, ...
By EDAP TMS
-
Tactile Medical to Participate in the Oppenheimer Healthcare Conference
Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, today announced that management will participate in Oppenheimer’s 32nd Annual Healthcare Conference, which is being held virtually from March 15th-16th. Management will ...
-
Durable Healing Outcomes of Topical Wound Oxygen (TWO2) Therapy Highlighted at Leading International Clinical Conferences
Advanced Oxygen Therapy Inc. (AOTI) announced today that its unique multimodality Topical Wound Oxygen (TWO2) therapy was recently highlighted at multiple leading international clinical conferences across the United States and United Kingdom. AOTI participated both as a sponsor and exhibitor at these events that were conducted in a hybrid format, where attendance could be either in person, or ...
-
Tactile Medical to Present at the William Blair 42nd Annual Growth Stock Conference
Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, today announced that management will participate in the William Blair 42nd Annual Growth Stock Conference, which is being held at the Loews Chicago Hotel in Chicago, Il from June ...
-
PreludeDx to Present DCIS Study Results Assessing Benefit of Adjuvant Endocrine Therapy Using DCISionRT During Oral Presentation at ASCO 2022 Annual Meeting
Prelude Corporation (PreludeDx, a leader in molecular diagnostics and precision medicine for early-stage breast cancer, announced today that its study in 926 DCIS patients demonstrating the clinical utility of DCISionRT? was selected for an oral presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting. The results evaluating the association of DCISionRT, a predictive DCIS ...
By PreludeDx
-
Nevro to Highlight New Clinical Evidence at the 2021 North American Neuromodulation Society (NANS) Virtual Meeting
Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced a series of data presentations supporting the use of the company's HF10® therapy for patients with chronic pain. Results will be presented at the 2021 North American Neuromodulation Society (NANS) Virtual Meeting held from January ...
By Nevro Corp.
-
BioStable Science & Engineering Announces CE Mark Approval for the HAART 200 Aortic Annuloplasty Device & Surpasses 1,000 Patients Treated Worldwide with the HAART Devices
BioStable Science & Engineering, Inc., (“BioStable”) announced today the company has received CE Mark approval for the HAART 200 Aortic Annuloplasty Device for use during bicuspid aortic valve repair. With CE Mark approval of both the HAART 300 and HAART 200 Aortic Annuloplasty Devices, BioStable will be able to offer surgeons within the European Union a comprehensive portfolio of ...
-
Cell Therapy Re-brands as Celixir
Celixir, a leading British biotechnology company delivering breakthrough regenerative medicines, has today rebranded from Cell Therapy. The change reflects the company’s continued commitment to discovering, developing and delivering life-altering regenerative medicines, and transforming patient care. “The name Celixir combines ‘Cell’ with the Latin root word elixir to ...
By Celixir plc
-
Reflow Medical Announces 510(K) Clearance For An Expanded Indication For The Wingman Catheter To Cross Chronic Total Occlusions (CTOs) In Peripheral Artery Disease
Reflow Medical, Inc., a California-based medical device company, has announced that they have received clearance from the FDA for an expanded indication for the Wingman™ Crossing Catheter after completing the Wing-IT clinical trial. The Wingman Catheter crosses peripheral CTOs using an extendable beveled tip that creates a channel to help penetrate, or cross, the occlusion with a guidewire, ...
-
WATS3D AI Platform Included in American Gastroenterological Association (AGA) Clinical Practice Update on New Technology and Innovation for Surveillance and Screening in Barrett’s Esophagus
CDx Diagnostics, Inc. announced that the WATS3D view, published in Clinical Gastroenterology and Hepatology. WATS3D uses a unique wide-area sampling instrument, proprietary 3D imaging with AI analysis, and expert pathologists to reliably identify abnormal cells to help physicians prevent esophageal cancer. “The CPU is based on a thorough review of the existing clinical literature and ...
-
Announcement of Appointment of Board Members
Today Baymatob welcomes the formal appointment of Tony Barclay and Alwyn Reynolds to our Board of Directors. Baymatob has been lucky enough to benefit from both Tony and Alwyn’s impressive and complimentary expertise in an advisory capacity to date, with their formal appointments reflecting the value we already know they deliver. These strategic appointments come at a significant time for ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you